Back to mobile site

Wells Fargo Upgrades Celldex Therapeutics (CLDX) to Equal Weight

November 10, 2023 5:05 AM EST
Get Alerts CLDX Hot Sheet
Price: $38.15 -2.45%

Rating Summary:
    18 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 16 | Down: 7 | New: 42
Join SI Premium – FREE

Wells Fargo analyst Derek Archila upgraded Celldex Therapeutics (NASDAQ: CLDX) from Underweight to Equal Weight with a price target of $27.00.


For an analyst ratings summary and ratings history on Celldex Therapeutics click here. For more ratings news on Celldex Therapeutics click here.


Shares of Celldex Therapeutics closed at $25.78 yesterday.


You May Also Be Interested In





Related Categories

Upgrades